1H-n.m.r. analysis of glycolipids possessing mono- and multi-meric X and Y haptens: characterization of two novel extended Y structures from human adenocarcinoma.

[1]  S. Hakomori,et al.  Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. , 1985, Cancer research.

[2]  M. Breimer,et al.  Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids. , 1985, The Journal of biological chemistry.

[3]  S. Hakomori,et al.  Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). , 1985, The Journal of biological chemistry.

[4]  S. Hakomori,et al.  Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. , 1985, Journal of immunology.

[5]  A. Dell,et al.  Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. , 1985, The Journal of biological chemistry.

[6]  S. Hakomori.  Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulators of cell proliferation , 1984 .

[7]  S. Hakomori,et al.  Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). , 1984, The Journal of biological chemistry.

[8]  J. Peter-Katalinic,et al.  Structures of fucose‐containing ceramide pentasaccharides from the plasma of blood group O Le(a−b−) nonsecretors , 1984, FEBS letters.

[9]  S. Hakomori,et al.  Glycolipid antigens with blood group I and i specificities from human adult and umbilical cord erythrocytes. , 1984, Journal of immunology.

[10]  Y. Hirabayashi,et al.  Isolation and characterization of a novel phytosphingosine-containing GM2 ganglioside from mullet roe (Mugil cephalus). , 1984, The Journal of biological chemistry.

[11]  S. Hakomori,et al.  Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. , 1984, The Journal of biological chemistry.

[12]  S. Hakomori,et al.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. , 1984, The Journal of biological chemistry.

[13]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.

[14]  I. Bernstein,et al.  A granulocyte reactive monoclonal antibody, 1G10, identifies the Gal beta 1-4 (Fuc alpha 1-3)GlcNAc (X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules. , 1983, Blood.

[15]  S. Hakomori,et al.  The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). , 1983, The Journal of biological chemistry.

[16]  S. Hakomori,et al.  Glycosphingolipids as tumor-associated and differentiation markers. , 1983, Journal of the National Cancer Institute.

[17]  S. Hakomori,et al.  Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosylα2→6galactosyl residue: A preliminary note , 1983 .

[18]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[19]  J. Prestegard,et al.  High-resolution proton NMR studies of gangliosides. 1. Use of homonuclear two-dimensional spin-echo J-correlated spectroscopy for determination of residue composition and anomeric configurations. , 1983, Biochemistry.

[20]  J. H. Shaper,et al.  My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III. , 1983, Blood.

[21]  R. Lemieux,et al.  The conformational analysis of oligosaccharides by H-NMR and HSEA calculation. , 1983, Archives of biochemistry and biophysics.

[22]  J. Vliegenthart,et al.  High-Resolution, 1H-Nuclear Magnetic Resonance Spectroscopy as a Tool in the Structural Analysis of Carbohydrates Related to Glycoproteins , 1983 .

[23]  J. Minna,et al.  Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. , 1983, Archives of biochemistry and biophysics.

[24]  S. Hakomori,et al.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. , 1982, The Journal of biological chemistry.

[25]  J. Le Pendu,et al.  Synthesis of type 2 human blood-group antigenic determinants. The H, X, and Y haptens and variations of the H type 2 determinant as probes for the combining site of the lectin I of Ulex europaeus. , 1982, Carbohydrate research.

[26]  E. L. Smith,et al.  Lewis blood group fucolipids and their isomers from human and canine intestine. , 1982, The Journal of biological chemistry.

[27]  Bernd Meyer,et al.  Further justification for the exo-anomeric effect. Conformational analysis based on nuclear magnetic resonance spectroscopy of oligosaccharides , 1982 .

[28]  H. Egge,et al.  Analysis of glycosphingolipids by high-resolution proton nuclear magnetic resonance spectroscopy. , 1982, Methods in enzymology.

[29]  H. Egge,et al.  Immunochemistry of the Lewis-blood-group system: mass spectrometric analysis of permethylated Le(a)-, Le(b)-, and H-type 1 (LedH) blood-group active and related glycosphingolipids from human plasma. , 1981, Archives of biochemistry and biophysics.

[30]  H. Egge,et al.  Immunochemistry of the Lewis-blood-group system: proton nuclear magnetic resonance study of plasmatic Lewis-blood-group-active glycosphingolipids and related substances. , 1981, Archives of biochemistry and biophysics.

[31]  D. Solter,et al.  Stage-specific embryonic antigen involves αl→ 3 fucosylated type 2 blood group chains , 1981, Nature.

[32]  D. Solter,et al.  The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note. , 1981, Biochemical and biophysical research communications.

[33]  H. Egge,et al.  Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy. , 1980, Biochemistry.

[34]  K. Bock,et al.  The conformations of oligosaccharides related to the ABH and Lewis human blood group determinants , 1980 .

[35]  H. Egge.  The application of mass spectrometry in the structural elucidation of glycosphingolipids , 1978 .

[36]  M. Anteunis,et al.  Experimental data for gauche couplings in carbohydrates , 1976 .

[37]  S. Hakomori,et al.  A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3. , 1971, The Journal of biological chemistry.